Cardiology Medical Device Market

In the medical industry, cardiovascular diseases have been a major pain point. Conditions such as ischemic heart disease and stroke significantly contribute to disability and mortality across the globe. As a result, the significance of cardiovascular devices (CVDs)for treating heart-related problems has seen a tremendous rise. In a study published by the American College of cardiology journal, nearly 1/3rd of all mortality worldwide in 2019 were due to cardiovascular diseases. These harrowing statistics highlight the importance of implementing technology, therapies, and health programs to mitigate CVDs risks. Here is the market overview and emerging trends in cardiovascular devices:

Market Overview

In the year 2020, the market of cardiovascular devices (CVDs) was valued at around USD 42,105 million, and for the period of 2021-2026, it's expected to register a CAGR of around 6.4%. The COVID-19 pandemic curtailed the production of CVDs. Additionally, the delay of elective procedures due to the pandemic measures has negatively impacted the cardiology medical device market. Since the start of the pandemic, some CVDs have been deemed urgent, while others have encountered delays or postponements. Further, most of the healthcare resources have been diverted towards COVID-19 patients leading to a reduction in cardiovascular disease diagnosis.

However, the market is expected to witness a boost due to many drivers. The key driver is the global rise of coronary heart diseases like cardiomyopathy and stroke, which leads to cardia deaths. Cardiovascular diseases are prevalent across the globe, and they are one of the leading causes of death. Further, technologies utilized for developing CVDs have significantly improved, and these devices indications have expanded. Artificial Intelligence (AI) is one such technology that has had a very positive impact on CVDs.

On the downside, the stringent regulatory policies continue to restrain the growth of the cardiology medical device market. Further, if the CVDs don’t comply with the authorities’ guidelines, they'll not receive approval which will, in turn, lead to a massive loss of investment. Additionally, when they don’t meet the criteria, the chances of a recall are very high, which is common in the CVD market. In the next section, we analyze the current trends in the market.

Rise of Advanced Cardiac Ablation Devices:

Cardiovascular diseases are one of the most significant burdens on the world medical domain, which only continues to rise. As a result, the utilization of innovative technological treatments will continue to see an upward rise creating profitable opportunities for the CVDs industry for the coming years. More than 72% of the market share was dominated by cardiac ablation devices, and this is only expected to grow. The significance of atrial fibrillation is a huge factor to the device’s popularity. These devices address a skyrocketing demand for sophisticated and ablation procedures that are as minimally invasive as possible.

For instance, in June of 2020, the DIRECTSENSE was introduced by Boston Scientific as equipment to study the radiofrequency energy delivery impact during cardiac ablation processes.

Monitoring and Diagnostic Segment Dominated By ECG .

On the monitoring and diagnostic segment, compact and portable ECG is compelling wider adoption particularly in the home healthcare area. Cardiovascular diseases that require prolonged ECG monitoring has witnessed an unprecedented increase. Additionally, with the development of wireless ECG, doctors can now remotely monitor and diagnose patients on time which further bolsters market growth.

Market Revenue Continues To Be Dominated By The US.

Due to the increasing demand for continuous and home-based monitoring, rising geriatric population, presence of reimbursements, high adoption rate of minimally invasive procedures, and high prevalence of cardiovascular diseases, the market for cardiovascular devices continues to be dominated by the US. Health Library estimates that more than 80 million people in the US suffers from some sort of cardiovascular disease. Additionally, the technological advancements and development in the cardiovascular field will boost the growth of the market.

Adopting Minimally Invasive Treatments

In recent years, minimally invasive procedures have gained immense popularity due to a plethora of benefits, such as a lower chance of complications, less pain, and less body damage. Highlighted during the 90s, these procedures succeeded the first valve bypass for heart and coronary artery performances through minimally invasive methods.

This surging interest in minimal invasion procedure is compelled by the development of devices for cardiovascular medical technologies. Such advancements are critical in promoting procedures that are minimally invasive as the favored operating method because they predominantly use specialized medical tools such as catheters to be placed inside the body via tiny incisions, whether for diagnostic measurements or therapeutic interventions.

For example, innovations such as the catheter called smart-balloon systems come with mechanisms, sensors, and electronics. They are routinely redesigned and updated to deliver electrical stimulation, hematological data, blood flow data, and ablation therapy through s single device.

Email Marketing Of Cardiology Devices

The increasing advancement and demand for cardiology devices have also led to a huge market for these devices. According to a report, email marketing has an ROI of 4400%. By 2021, email users are expected to grow to 4.3 billion. Even when it comes to marketing cardiology medical devices, many marketers resort to email marketing, and it is only expected to see an upward trend. However, this has also led to a mushrooming of medicoreach email list buying services and sites. Medicoreach offers the most comprehensive email list and also provides marketing services across a plethora of channels. Services like Medicoreach are critical for generating sales and revenue.

Big Companies Pursuing Portfolio Expansion Will Intensify Market Competition

As of now, the market share of cardiovascular devices is dominated by three major companies namely Abbott, Medtronic, and Boston Scientific Corporation. These companies have been able to generate high revenue due to their extensive product catalog that includes advanced stents, heart valves, and other cardiovascular products. Manufacturers are focusing on cardiopulmonary production which will increase the scope of generating higher revenues particularly from patients that were previously untreatable.

Conclusion

As the importance of tackling cardiovascular and related diseases come to the forefront of the health industry, the cardiology medical device market is expected to grow. This is also due to the increasing awareness through the internet, governmental public healthcare programs, and private hospital heart programs. Thanks to this increasing awareness, consumers are becoming conscious of cardiovascular disease symptoms, the importance of early diagnosis, and available treatments. As the populace becomes aware of the advancements in CVDs, the market will continue to grow. Comprehensive Cardiology email marketing will reach to the right audience looking for medical device .